Found: 84
Select item for more details and to access through your institution.
Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5102, doi. 10.1002/alz.13883
- By:
- Publication type:
- Article
Subjective cognitive decline and anxious/depressive symptoms during the COVID-19 pandemic: what is the role of stress perception, stress resilience, and β-amyloid?
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01068-7
- By:
- Publication type:
- Article
Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer's continuum.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00878-5
- By:
- Publication type:
- Article
Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00863-y
- By:
- Publication type:
- Article
Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00781-z
- By:
- Publication type:
- Article
Harmonization of brain PET images in multi-center PET studies using Hoffman phantom scan.
- Published in:
- EJNMMI Physics, 2023, v. 10, n. 1, p. 1, doi. 10.1186/s40658-023-00588-x
- By:
- Publication type:
- Article
P‐tau235: a novel biomarker for staging preclinical Alzheimer's disease.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 12, p. 1, doi. 10.15252/emmm.202115098
- By:
- Publication type:
- Article
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 12, p. 1, doi. 10.15252/emmm.202012921
- By:
- Publication type:
- Article
Impact of APOE‐ε4 on cerebral amyloid deposition in participants with abnormal soluble amyloid levels: Amyloid imaging.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045828
- By:
- Publication type:
- Article
Harmonization of amyloid PET scans minimizes the impact of reconstruction parameters on centiloid values: Neuroimaging / Optimal neuroimaging measures for tracking disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045294
- By:
- Publication type:
- Article
Multiple pathophysiological biomarkers are associated with gray matter volume and cerebral glucose metabolism in the early preclinical Alzheimer's continuum: Neuroimaging / multi‐modal comparisons.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044808
- By:
- Publication type:
- Article
Higher fronto‐parietal metabolism parallels a greater impact of amyloid and anxiety on medial temporal areas in women versus men: Neuroimaging / multi‐modal comparisons.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044780
- By:
- Publication type:
- Article
Multiple biological pathways associate with cerebral amyloid load in the early Alzheimer's continuum: Neuroimaging / Optimal neuroimaging measures for early detection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044733
- By:
- Publication type:
- Article
Impact of the APOE gene on amyloid deposition in participants with abnormal soluble amyloid levels: Early imaging changes in cognitively normal subjects at risk of late onset AD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042955
- By:
- Publication type:
- Article
Genetic, vascular and amyloid components of cerebral blood flow in a preclinical population.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2023, v. 43, n. 10, p. 1726, doi. 10.1177/0271678X231178993
- By:
- Publication type:
- Article
Regional associations of white matter hyperintensities and early cortical amyloid pathology.
- Published in:
- Brain Communications, 2022, v. 4, n. 3, p. 1, doi. 10.1093/braincomms/fcac150
- By:
- Publication type:
- Article
Brain alterations in the early Alzheimer's continuum with amyloid-β, tau, glial and neurodegeneration CSF markers.
- Published in:
- Brain Communications, 2022, v. 4, n. 3, p. 1, doi. 10.1093/braincomms/fcac134
- By:
- Publication type:
- Article
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 12, p. 1471, doi. 10.1001/jamaneurol.2021.3671
- By:
- Publication type:
- Article
Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer's continuum.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4567, doi. 10.1007/s00259-022-05897-4
- By:
- Publication type:
- Article
Quantification of amyloid PET for future clinical use: a state-of-the-art review.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3508, doi. 10.1007/s00259-022-05784-y
- By:
- Publication type:
- Article
A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2183, doi. 10.1007/s00259-021-05311-5
- By:
- Publication type:
- Article
Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 7, p. 2169, doi. 10.1007/s00259-020-05174-2
- By:
- Publication type:
- Article
Biological brain age prediction using machine learning on structural neuroimaging data: Multi-cohort validation against biomarkers of Alzheimer’s disease and neurodegeneration stratified by sex.
- Published in:
- eLife, 2023, p. 1, doi. 10.7554/eLife.81067
- By:
- Publication type:
- Article
APOE-ε4 modulates the association between regional amyloid deposition and cognitive performance in cognitively unimpaired middle-aged individuals.
- Published in:
- EJNMMI Research, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13550-023-00967-6
- By:
- Publication type:
- Article
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 5, p. 3429, doi. 10.1002/alz.13761
- By:
- Publication type:
- Article
Astrocyte biomarkers GFAP and YKL‐40 mediate early Alzheimer's disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 1, p. 483, doi. 10.1002/alz.13450
- By:
- Publication type:
- Article
The effects of a 24‐weeks resistance exercise intervention on global brain amyloid beta levels: Preliminary results of AGUEDA randomized controlled trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082923
- By:
- Publication type:
- Article
Amyloid predicts longitudinal atrophy in non‐demented individuals: Results from the AMYPAD Prognostic & Natural History study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082845
- By:
- Publication type:
- Article
Optimizing plasma biomarkers combinations for the detection of amyloid pathology in cognitively unimpaired individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082742
- By:
- Publication type:
- Article
Associations between gait velocity parameters and brain amyloid‐β levels in cognitive normal older adults: a cross‐sectional analysis from the AGUEDA trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082721
- By:
- Publication type:
- Article
The associations between glial biomarkers and cognitive changes in individuals at risk of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082594
- By:
- Publication type:
- Article
Reproductive span as a modifier of the association between AD biomarkers and cognitive decline in cognitively unimpaired women.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 22, p. 1, doi. 10.1002/alz.078662
- By:
- Publication type:
- Article
Association between blood pressure and Alzheimer's disease biomarkers in cognitively unimpaired adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 22, p. 1, doi. 10.1002/alz.076777
- By:
- Publication type:
- Article
Amyloid‐PET Centiloid quantification predicts cognitive functioning in a pre‐dementia population: findings from AMYPAD‐PNHS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078684
- By:
- Publication type:
- Article
Exploring biomarker profiles of the cognitively unimpaired individuals in early tau PET Braak stage.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077921
- By:
- Publication type:
- Article
A Centiloid cut‐off to help predict true amyloid accumulation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074619
- By:
- Publication type:
- Article
Evaluating the sensitivity of Centiloid quantification to pipeline design and image harmonization.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074616
- By:
- Publication type:
- Article
Comparing parametric methods for longitudinal measurement of β‐amyloid pathology with PET in elderly individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079545
- By:
- Publication type:
- Article
CSF sTREM2 and YKL‐40 modify the balance between soluble and fibrillary β‐amyloid in non‐demented individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078807
- By:
- Publication type:
- Article
Brain‐age mediates the association between modifiable risk factors and cognitive decline early in the AD continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078202
- By:
- Publication type:
- Article
CSF Aβ42/40 is associated with neurodegeneration independently of CSF p‐tau in the earliest AD continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074606
- By:
- Publication type:
- Article
Cognitively Unimpaired Multiparous Women Have Higher CSF p‐tau181 Levels Which Have More Deleterious Effects on Neurodegeneration and Executive Function.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078157
- By:
- Publication type:
- Article
Plasma biomarkers rates of change across the preclinical stage of Alzheimer's disease: a longitudinal study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079638
- By:
- Publication type:
- Article
Self‐reported COVID‐19 and biomarkers of Alzheimer's disease: interim analyses from an Alzheimer's disease risk‐enriched cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077721
- By:
- Publication type:
- Article
Different astrocyte phenotypes mediate the pathological cascade early in the Alzheimer's disease continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074674
- By:
- Publication type:
- Article
Differential associations between regional amyloid PET and Alzheimer's disease polygenic risk scores.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.071266
- By:
- Publication type:
- Article
A Centiloid cut‐off to help predict true amyloid accumulation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.082037
- By:
- Publication type:
- Article
Evaluating the sensitivity of Centiloid quantification to pipeline design and image harmonization.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.082036
- By:
- Publication type:
- Article
Comparing parametric methods for longitudinal measurement of β‐amyloid pathology with PET in elderly individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081913
- By:
- Publication type:
- Article
CSF sTREM2 and YKL‐40 modify the balance between soluble and fibrillary β‐amyloid in non‐demented individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081843
- By:
- Publication type:
- Article